Skip to content
Clinical Trials – home

Exploring Desmopressin in Clinical Trials: Applications, Efficacy, and Safety

1 / 1
trials open to patients / all trials
1+
Countries

In short

Desmopressin (also known as DDAVP) is a synthetic analog of the natural hormone vasopressin that has been studied extensively in various clinical settings. This medication works primarily by increasing water reabsorption in the kidneys and promoting the release of clotting factors from blood vessel walls. Clinical trials have investigated desmopressin across diverse conditions including nocturnal enuresis (bedwetting), nocturia (excessive nighttime urination), bleeding disorders, Parkinson's disease, and more. This article summarizes the current research on desmopressin's applications, effectiveness, and safety considerations based on recent clinical trials.

Key points

  • Desmopressin is a synthetic hormone that has shown effectiveness across multiple clinical trials for treating conditions involving excessive urination and certain bleeding disorders. For nocturnal enuresis (bedwetting), it significantly reduces wet nights in both children and adults, with the oral melt formulation showing better absorption than tablets. In nocturia, desmopressin decreases nighttime voids and improves sleep quality, particularly in patients with nocturnal polyuria. For patients with mild hemophilia A, it can temporarily increase clotting factors, providing an alternative to factor concentrate treatments. Desmopressin has also shown promise for managing bleeding in surgical settings and treating nocturnal urination in Parkinson's patients. Hyponatremia (low blood sodium) remains the most significant safety concern, requiring careful patient selection and monitoring.

What is desmopressin?

Desmopressin (also known as DDAVP) is a synthetic version of vasopressin, a natural hormone produced by the pituitary gland. It was developed as a medication to help the body manage fluid balance and prevent excessive urination. Desmopressin is a selective agonist (activator) of the vasopressin type 2 receptor, which affects water reabsorption in the kidneys .

Common brand names for desmopressin include Minirin, Minirin Melt, Nocturin, and DDAVP. It has been used medically for decades and is on the World Health Organization's List of Essential Medicines .

How Desmopressin Works

Desmopressin functions primarily by mimicking the action of antidiuretic hormone (ADH) released by the posterior pituitary gland. When it binds to vasopressin type 2 receptors in the kidneys, it triggers increased water reabsorption in the collecting tubules. This reduces urine production and makes the urine more concentrated .

Additionally, desmopressin stimulates the release of von Willebrand factor (VWF) and Factor VIII from endothelial cells into the bloodstream. These are important clotting factors that help prevent or control bleeding. This makes desmopressin useful for treating certain bleeding disorders .

Medical Conditions Treated with Desmopressin

Nocturnal Enuresis (Bedwetting)

Desmopressin is widely used to treat nocturnal enuresis (bedwetting) in children and adults. By reducing urine production at night, it helps prevent bedwetting episodes. Clinical trials have shown that desmopressin can significantly reduce the number of wet nights in patients with this condition .

For monosymptomatic nocturnal enuresis (bedwetting without other bladder symptoms), desmopressin is considered a first-line treatment alongside behavioral strategies. It's particularly effective in children with reduced nighttime urinary concentration capacity .

Nocturia and Nocturnal Polyuria

Nocturia (frequent nighttime urination) caused by nocturnal polyuria (excessive urine production at night) can significantly affect sleep quality and overall well-being. Desmopressin helps reduce nighttime urination frequency by decreasing urine production.

Clinical trials have demonstrated that desmopressin significantly reduces the number of nighttime voids and increases the initial period of undisturbed sleep in patients with nocturia .

Diabetes Insipidus

Central diabetes insipidus is a condition characterized by insufficient production of vasopressin, leading to excessive thirst and urination. Desmopressin effectively treats this condition by replacing the missing hormone .

Bleeding Disorders

Desmopressin is used to treat or prevent bleeding in patients with mild to moderate hemophilia A, von Willebrand disease, and certain platelet function disorders. It works by increasing the levels of clotting factors in the blood.

Clinical trials have shown that intravenous desmopressin can increase Factor VIII levels significantly in patients with mild hemophilia A and in carriers of the hemophilia A gene . It's also being studied for use in platelet dysfunction associated with mild hypothermia and in patients taking aspirin or other medications that affect platelet function .

Other Medical Conditions

Research is ongoing into other potential uses for desmopressin, including:

  • Reducing postoperative bleeding in cardiac and other surgeries
  • Managing bleeding in colorectal cancer patients
  • Controlling bedwetting in patients with sickle cell disease
  • Treating nocturnal enuresis in patients after bladder reconstruction surgery
  • Managing nocturnal micturition frequency in patients with Parkinson's disease

Available Formulations

Desmopressin is available in several different formulations:

  • Oral tablets: Traditional tablets that are swallowed with water
  • Oral lyophilisate (MELT): A tablet that dissolves quickly when placed under the tongue, without the need for water. This formulation has better bioavailability (0.5%) compared to traditional tablets (0.2%)
  • Nasal spray: Applied directly into the nasal cavity (has higher bioavailability at about 2%, but carries an increased risk of hyponatremia)
  • Injectable solution: For intravenous or subcutaneous administration, usually in hospital settings

The choice of formulation depends on the condition being treated, patient preference, and the specific needs of the patient. For example, the MELT formulation may be more suitable for children who have difficulty swallowing tablets .

Dosage Information

Dosages of desmopressin vary depending on the condition being treated, the patient's age, weight, and the specific formulation being used:

  • For nocturnal enuresis in children: Typically 120-240 μg of oral lyophilisate or 0.2-0.4 mg of tablet formulation taken at bedtime
  • For nocturia in adults: Usually 25-50 μg of oral lyophilisate or 0.1-0.4 mg of tablet formulation taken at bedtime
  • For hemophilia A and von Willebrand disease: Typically 0.3 μg/kg administered intravenously or subcutaneously
  • For diabetes insipidus: Dosing is individualized based on response, typically starting with lower doses and titrating upward as needed

It's important to follow your doctor's prescription exactly. Taking more than the prescribed dose can lead to serious side effects, particularly water retention and hyponatremia (low sodium levels in the blood).

Potential Side Effects

Like all medications, desmopressin can cause side effects. Common side effects include:

  • Headache
  • Nausea
  • Mild abdominal pain
  • Facial flushing
  • Nasal congestion (with nasal spray formulation)

The most serious potential side effect is hyponatremia (low sodium levels in the blood), which can occur if there's excessive water retention. Symptoms of hyponatremia include:

  • Headache
  • Nausea and vomiting
  • Confusion
  • Seizures
  • In severe cases, coma

The risk of hyponatremia is higher in elderly patients and those who drink large amounts of fluid while taking desmopressin. Clinical trials have monitored sodium levels closely, particularly during the first week of treatment .

Other less common side effects reported in clinical trials include:

  • Increased blood pressure
  • Dizziness
  • Diarrhea
  • Dry mouth (xerostomia)
  • Dry eyes (xerophthalmia)
  • Blurred vision
  • Difficulty swallowing
  • Constipation
  • Rhinitis

Precautions and Contraindications

Desmopressin should be used with caution in certain situations and is contraindicated (should not be used) in others:

Contraindications:

  • Hyponatremia (low sodium levels)
  • Habitual or psychogenic polydipsia (excessive drinking)
  • Severe renal impairment (creatinine clearance below 50 ml/min)
  • Congestive heart failure
  • Known hypersensitivity to desmopressin

Use with caution in patients with:

  • Conditions associated with fluid and electrolyte imbalance
  • Moderate renal impairment
  • Cardiovascular disease
  • Hypertension
  • Cystic fibrosis
  • Advanced age (elderly patients are at increased risk of hyponatremia)

Fluid intake should be limited to a minimum from 1 hour before until 8 hours after taking desmopressin to reduce the risk of water intoxication and hyponatremia .

Use in Special Populations

Children

Desmopressin is widely used in children for the treatment of nocturnal enuresis. The oral lyophilisate (MELT) formulation is often preferred for children as it doesn't require water for administration and has better bioavailability. Studies have shown that desmopressin is effective and generally well-tolerated in children when used at appropriate doses .

Elderly Patients

Elderly patients are at increased risk of developing hyponatremia with desmopressin treatment. Lower doses may be required, and sodium levels should be monitored carefully, especially at the start of treatment. Fluid restriction is particularly important in this population .

Patients with Sickle Cell Disease

Research is ongoing into the use of desmopressin for treating nocturnal enuresis in patients with sickle cell disease. Preliminary studies suggest it may be effective, but more research is needed to fully establish its safety and efficacy in this population .

Pregnant Women

There are limited data on the use of desmopressin during pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus. Always consult with your healthcare provider if you are pregnant or planning to become pregnant.

Current Research and Future Applications

Ongoing research is exploring new applications for desmopressin:

  • Cancer Treatment: Studies are investigating the potential role of desmopressin in cancer treatment, particularly for breast and colorectal cancers. Preliminary research suggests it might help reduce the formation of metastases by affecting the survival of circulating tumor cells .
  • Surgical Applications: Research is examining the use of desmopressin to reduce bleeding in various surgical procedures, including cardiac valve surgery, rhinoplasty, and surgeries in patients with acquired von Willebrand disease .
  • Personalized Medicine: Studies are looking at genetic factors that influence response to desmopressin, particularly in hemophilia A patients and carriers. This could lead to more personalized treatment approaches in the future .

As research continues, our understanding of desmopressin's effects and potential applications continues to grow. This may lead to improved treatment protocols and new therapeutic uses in the future.

Questions people often ask

Conditions where Desmopressin is being studied

Each condition opens its own overview and trial list

Trials with Desmopressin

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.